Impersonalized medicine

Heidi Scrable

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Research reported in this issue of Science Translational Medicine illustrates the benefits of short-term food withdrawal (fasting) in the treatment of cancer. Fasting exploited fundamental differences in the way tumor cells and normal cells respond to stress, simultaneously strengthening normal cell function and weakening tumor cell survival in the presence of toxic doses of chemotherapeutic drugs.

Original languageEnglish (US)
JournalScience Translational Medicine
Volume4
Issue number124
DOIs
StatePublished - Mar 7 2012

Fingerprint

Medicine
Fasting
Neoplasms
Translational Medical Research
Poisons
Cell Survival
Food
Research
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Impersonalized medicine. / Scrable, Heidi.

In: Science Translational Medicine, Vol. 4, No. 124, 07.03.2012.

Research output: Contribution to journalArticle

Scrable, Heidi. / Impersonalized medicine. In: Science Translational Medicine. 2012 ; Vol. 4, No. 124.
@article{9947bb7b07684225a96987781fdc8048,
title = "Impersonalized medicine",
abstract = "Research reported in this issue of Science Translational Medicine illustrates the benefits of short-term food withdrawal (fasting) in the treatment of cancer. Fasting exploited fundamental differences in the way tumor cells and normal cells respond to stress, simultaneously strengthening normal cell function and weakening tumor cell survival in the presence of toxic doses of chemotherapeutic drugs.",
author = "Heidi Scrable",
year = "2012",
month = "3",
day = "7",
doi = "10.1126/scitranslmed.3003738",
language = "English (US)",
volume = "4",
journal = "Science Translational Medicine",
issn = "1946-6234",
publisher = "American Association for the Advancement of Science",
number = "124",

}

TY - JOUR

T1 - Impersonalized medicine

AU - Scrable, Heidi

PY - 2012/3/7

Y1 - 2012/3/7

N2 - Research reported in this issue of Science Translational Medicine illustrates the benefits of short-term food withdrawal (fasting) in the treatment of cancer. Fasting exploited fundamental differences in the way tumor cells and normal cells respond to stress, simultaneously strengthening normal cell function and weakening tumor cell survival in the presence of toxic doses of chemotherapeutic drugs.

AB - Research reported in this issue of Science Translational Medicine illustrates the benefits of short-term food withdrawal (fasting) in the treatment of cancer. Fasting exploited fundamental differences in the way tumor cells and normal cells respond to stress, simultaneously strengthening normal cell function and weakening tumor cell survival in the presence of toxic doses of chemotherapeutic drugs.

UR - http://www.scopus.com/inward/record.url?scp=84858045383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858045383&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.3003738

DO - 10.1126/scitranslmed.3003738

M3 - Article

C2 - 22399263

AN - SCOPUS:84858045383

VL - 4

JO - Science Translational Medicine

JF - Science Translational Medicine

SN - 1946-6234

IS - 124

ER -